Items where Author is "Abu-Gharbieh, E."

(2026) Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990-2023: a Global Burden of Disease Study. Nature Medicine. pp. 527-544. ISSN 1078-8956

(2026) Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Infectious Diseases. pp. 343-361. ISSN 1473-3099

(2026) Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study. Nature Medicine. pp. 1454-1478. ISSN 1078-8956

(2026) Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Oncology. pp. 302-326. ISSN 1470-2045

(2026) Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study. Nature Medicine. p. 46. ISSN 1078-8956

(2026) Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Neurology. pp. 451-468. ISSN 1474-4422

(2026) Measuring the composition and availability of human resources for health by sex in 204 countries and territories, 1990–2023, and workforce gaps for universal health coverage: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Public Health. e604-e629. ISSN 24682667 (ISSN)

(2025) Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1873-1922. ISSN 0140-6736

(2025) Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. The Lancet Public Health. e172-e188. ISSN 24682667 (ISSN)

(2025) Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nature Communications. p. 36.

(2025) Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950-2023: a demographic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1731-1810. ISSN 0140-6736

(2025) Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1811-1872. ISSN 0140-6736

(2025) Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. Jacc-Journal of the American College of Cardiology. pp. 2167-2243. ISSN 0735-1097

(2025) Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 519-536. ISSN 14733099 (ISSN)

(2025) Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Respiratory Medicine. pp. 425-446. ISSN 2213-2600

(2025) Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 36-51. ISSN 14733099 (ISSN)

(2025) Global, regional, and national burden of upper respiratory infections and otitis media, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 36-51. ISSN 14733099 (ISSN)

(2025) Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. The Lancet. pp. 785-812. ISSN 01406736 (ISSN)

(2025) Global, regional, and national prevalence of kidney failure with replacement therapy and associated aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Global Health. E1378-E1395. ISSN 2214-109X

(2025) Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 235-260. ISSN 0140-6736

(2025) The global, regional, and national burden attributable to low bone mineral density, 1990-2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021. Lancet Rheumatology. E873-E894. ISSN 2665-9913

(2025) The global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. pp. 1565-1586. ISSN 0140-6736

(2024) Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2162-2203. ISSN 0140-6736

(2024) Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2100-2132. ISSN 0140-6736

(2024) Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020. Eye. pp. 2083-2101. ISSN 0950-222X

(2024) Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020. Eye. pp. 2156-2172. ISSN 0950-222X

(2024) Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020. Eye. pp. 2036-2046. ISSN 0950-222X

(2024) Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2057-2099. ISSN 0140-6736

(2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 2133-2161. ISSN 0140-6736

(2024) Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Infectious Diseases. pp. 698-725. ISSN 1473-3099

(2024) Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurology. pp. 344-381. ISSN 1474-4422

(2024) Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Neurology. pp. 973-1003. ISSN 14744422 (ISSN)

(2024) Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet. pp. 1955-1988. ISSN 0140-6736

(2024) Temporal patterns of cancer burden in Asia, 1990-2019: a systematic examination for the Global Burden of Disease 2019 study. Lancet Regional Health - Southeast Asia. p. 26. ISSN 2772-3682

(2024) Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021. Lancet Gastroenterology & Hepatology. pp. 825-858.

(2024) The burden of neurological conditions in north Africa and the Middle East, 1990-2019: a systematic analysis of the Global Burden of Disease Study 2019. Lancet Global Health. E960-E982. ISSN 2214-109X

(2023) Burden of breast cancer and attributable risk factors in the North Africa and Middle East region, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Frontiers in Oncology. ISSN 2234943X (ISSN)

(2023) Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026. Lancet Global Health. E385-E413. ISSN 2214-109X

(2023) The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories A Systematic Analysis for the Global Burden of Disease Study 2019. Jama Oncology. pp. 1401-1416. ISSN 2374-2437

(2023) Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Allergy: European Journal of Allergy and Clinical Immunology. pp. 2232-2254. ISSN 01054538 (ISSN)

(2023) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. pp. 203-234. ISSN 0140-6736

(2023) Global, regional, and national burden of meningitis and its aetiologies, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurology. pp. 685-711. ISSN 1474-4422

(2023) Global, regional, and national mortality due to unintentional carbon monoxide poisoning, 2000-2021: results from the Global Burden of Disease Study 2021. Lancet Public Health. E839-E849. ISSN 2468-2667

(2023) Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematology. E585-E599. ISSN 2352-3026

(2022) Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. Lancet Public Health. E657-E669. ISSN 2468-2667

(2022) Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infectious Diseases. pp. 1626-1647. ISSN 1473-3099

(2022) Burden of thyroid cancer in North Africa and Middle East 1990–2019. Frontiers in Oncology. ISSN 2234943X (ISSN)

(2022) Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterology & Hepatology. pp. 627-647.

(2022) Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019. LANCET INFECTIOUS DISEASES. pp. 222-241. ISSN 1473-3099 1474-4457 J9 - LANCET INFECT DIS

(2022) Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990–2019: results from the Global Burden of Disease Study 2019. The Lancet Infectious Diseases. pp. 222-241. ISSN 14733099 (ISSN)

(2022) Injury burden in individuals aged 50 years or older in the Eastern Mediterranean region, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. The Lancet Healthy Longevity. e253-e262. ISSN 26667568 (ISSN)

(2022) Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. The Lancet. pp. 185-235. ISSN 01406736 (ISSN)

(2022) The burden of prostate cancer in North Africa and Middle East, 1990–2019: Findings from the global burden of disease study. Frontiers in Oncology. ISSN 2234943X (ISSN)

(2022) The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. LANCET ONCOLOGY. pp. 27-52. ISSN 1470-2045 1474-5488 J9 - LANCET ONCOL

(2022) The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 563-591. ISSN 0140-6736

(2021) Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. Nature Medicine. pp. 1761-1782. ISSN 10788956 (ISSN)

(2021) Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019. LANCET. pp. 1593-1618. ISSN 0140-6736 1474-547X J9 - LANCET

(2021) Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. LANCET. pp. 870-905. ISSN 0140-6736 1474-547X J9 - LANCET

(2021) Mapping inequalities in exclusive breastfeeding in low- and middle-income countries, 2000–2018. Nature Human Behaviour. pp. 1027-1045. ISSN 23973374 (ISSN)

(2021) Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study. Lancet Hiv. E363-E375. ISSN 2352-3018

(2020) Five insights from the Global Burden of Disease Study 2019. Lancet. pp. 1135-1159. ISSN 0140-6736

(2020) Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. Journal of the American College of Cardiology. pp. 2982-3021. ISSN 07351097 (ISSN)

(2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 1204-1222. ISSN 0140-6736